The authors demonstrated that FLRT2 was implicated in breast cancer progression [33,34], specifically, the downregulation of FLRT2 was associated with inactivated hypermethylation during tumor formation causing increased proliferation and cell migration in breast cancer. The gene discussed is FLRT2; the disease is breast carcinoma.